RE: Today's RNS reality24 May 2024 15:08
I agree with the idea that as commercialisation nears, the value of the business should increase. We're not a million miles from having the funds now though. Flog Dx. Done. I'd rather they get decent value for it or retain it as a cash generator though. Ideally get the cash from a licence deal, but it'll have to be a bargain as BP won't pay a whacking sum when they can get the lot for not much more.
Regards approvals, it's obvious they're working with the FDA, I don't see an issue for approval for the indication they go with for P2.
I completely disagree they're in a position where they need to try to start a bidding war from such a low starting position. As said, they're not far from the cash needed for P2 which gets them to market and being self sustaining